Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.71 USD
Change Today +0.06 / 2.26%
Volume 3.7M
ARNA On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven W. Spector J.D.

Executive Vice President, General Counsel and Secretary,Arena Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Mr. Steven W. Spector, JD has been General Counsel, Executive Vice President and secretary at Arena Pharmaceuticals, Inc. since October 2001, February 2012 and November 2001 respectively. Mr. Spector served as Senior Vice President since of Arena Pharmaceuticals, Inc. He served as Vice President of Arena Pharmaceuticals Inc. from October 2001 to June 2004. Prior to joining Arena Pharmaceuticals Inc., Mr. Spector was a partner with the law firm of Morgan, Lewis & Bockius ...

Read Full Background

Corporate Headquarters*

6154 Nancy Ridge Drive
San Diego, California 92121

United States

Phone: 858-453-7200
Fax: 858-453-7210

Board Members Memberships*

There is no Board Members Memberships data available.


The University of Pennsylvania
The University of Pennsylvania

Other Affiliations*

Annual Compensation*

Total Annual Compensation$415,000

Stock Options*

Restricted Stock Awards$1,059,600
All Other Compensation$16,320
Exercised Options103,334
Exercised Options Value$386,666
Exercisable Options695,001
Exercisable Options Value$569,000
Unexercisable Options525,000
Unexercisable Options Value$563,500
Total Value of Options$1,519,166
Total Number of Options1,323,335

Total Compensation*

Total Annual Cash Compensation$595,245
Total Short Term Compensation$415,000
Other Long Term Compensation$1,075,920
Total Calculated Compensation$1,846,335
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARNA:US $2.71 USD +0.06


Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma Inc.
Raul R. Rodriguez Chief Executive Officer, President, Director and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
Rajesh C. Shrotriya M.D.Chairman and Chief Executive Officer
Spectrum Pharmaceuticals, Inc.
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Michael A. Narachi M.S., M.B.A.Chief Executive Officer, President and Director
Orexigen Therapeutics, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARENA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at